University of Sydney-ko ikertzaileekin lankidetzan egindako argitalpenak (61)

2024

  1. Toxicology Screening in Sports-Related Sudden Cardiac Death: A Multinational Observational Study

    JACC: Clinical Electrophysiology, Vol. 10, Núm. 3, pp. 515-523

2023

  1. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

    eClinicalMedicine, Vol. 64

  2. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

    JAMA Neurology, Vol. 80, Núm. 7, pp. 702-713

  3. Comparative effectiveness in multiple sclerosis: A methodological comparison

    Multiple Sclerosis Journal, Vol. 29, Núm. 3, pp. 326-332

  4. Disability accrual in primary and secondary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 9, pp. 707-717

  5. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

    Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883

  6. Polarimetric imaging for the detection of synthetic models of SARS-CoV-2: A proof of concept

    Journal of Quantitative Spectroscopy and Radiative Transfer, Vol. 302

  7. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

    Brain : a journal of neurology, Vol. 146, Núm. 11, pp. 4633-4644

  8. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 1014-1024

2022

  1. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study

    Neurology, Vol. 98, Núm. 24, pp. E2401-E2412

  2. Confirmed disability progression as a marker of permanent disability in multiple sclerosis

    European Journal of Neurology, Vol. 29, Núm. 8, pp. 2321-2334

  3. Development of a core outcome set for lateral elbow tendinopathy (COS-LET) using best available evidence and an international consensus process

    British Journal of Sports Medicine, Vol. 56, Núm. 12, pp. 657-666

  4. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

    Neurology, Vol. 99, Núm. 17, pp. E1926-E1944

  5. Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology and Hepatology

  6. Optical imaging spectroscopy for rapid, primary screening of SARS-CoV-2: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

    Multiple Sclerosis Journal, Vol. 27, Núm. 5, pp. 755-766

  2. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study

    Journal of Medical Screening

  3. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade

    Journal of global health, Vol. 11, pp. 15003

2020

  1. Risk of secondary progressive multiple sclerosis: A longitudinal study

    Multiple Sclerosis Journal, Vol. 26, Núm. 1, pp. 79-90

  2. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

    Emerging Infectious Diseases, Vol. 26, Núm. 11, pp. 2709-2712